Skip to content
10-Q

Quarterly Report

VITASPRING BIOMEDICAL CO. LTD.

0001640334-26-001075

← back to feed
Filed
Jun 17, 2026 11:43 AM ET
Period of report
Jun 17, 2026

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Jun 17, 2026 207.03M sh
Shares Diluted Q2 2026 · Jul 31, 2025 207.03M sh
Shares Diluted Q2 2026 · Jul 31, 2025 207.03M sh
Shares Diluted Q2 2026 · Jul 31, 2024 207.03M sh
Shares Diluted Q2 2026 · Jul 31, 2024 207.03M sh
Operating Cash Flow Q2 2026 · Jul 31, 2025 −$1.97K
Operating Cash Flow Q2 2026 · Jul 31, 2024 −$6.44K
Cash And Equivalents Q2 2026 · Jul 31, 2025 $0
Cash And Equivalents Q2 2026 · Jan 31, 2025 $0
Stockholders Equity Q2 2026 · Jul 31, 2025 −$4.21M
Stockholders Equity Q2 2026 · Apr 30, 2025 −$4.1M
Stockholders Equity Q2 2026 · Jan 31, 2025 −$4.02M
Stockholders Equity Q2 2026 · Jul 31, 2024 −$3.7M
Stockholders Equity Q2 2026 · Apr 30, 2024 −$3.53M
Stockholders Equity Q2 2026 · Jan 31, 2024 −$3.35M
Current Liabilities Q2 2026 · Jul 31, 2025 $4.22M
Current Liabilities Q2 2026 · Jan 31, 2025 $4.03M
Total Liabilities Q2 2026 · Jul 31, 2025 $4.22M
Total Liabilities Q2 2026 · Jan 31, 2025 $4.03M
Current Assets Q2 2026 · Jul 31, 2025 $7.89K
Current Assets Q2 2026 · Jan 31, 2025 $272
Total Assets Q2 2026 · Jul 31, 2025 $17.02K
Total Assets Q2 2026 · Jan 31, 2025 $14.38K
Eps Diluted Q2 2026 · Jul 31, 2025 $0.00
Eps Diluted Q2 2026 · Jul 31, 2025 $0.00
Eps Diluted Q2 2026 · Jul 31, 2024 $0.00
Eps Diluted Q2 2026 · Jul 31, 2024 $0.00
Sga Expense Q2 2026 · Jul 31, 2025 $99.07K
Sga Expense Q2 2026 · Jul 31, 2025 $168.21K
Sga Expense Q2 2026 · Jul 31, 2024 $218.66K
Sga Expense Q2 2026 · Jul 31, 2024 $435.49K
Net Income Q2 2026 · Jul 31, 2025 −$110.85K
Net Income Q2 2026 · Jul 31, 2025 −$191.39K
Net Income Q2 2026 · Apr 30, 2025 −$80.54K
Net Income Q2 2026 · Jul 31, 2024 −$218.66K
Net Income Q2 2026 · Jul 31, 2024 −$435.49K
Net Income Q2 2026 · Apr 30, 2024 −$216.83K
Operating Income Q2 2026 · Jul 31, 2025 −$99.07K
Operating Income Q2 2026 · Jul 31, 2025 −$168.21K
Operating Income Q2 2026 · Jul 31, 2024 −$218.66K
Operating Income Q2 2026 · Jul 31, 2024 −$435.49K
Revenue Q2 2026 · Jul 31, 2025 $0
Revenue Q2 2026 · Jul 31, 2025 $0
Revenue Q2 2026 · Jul 31, 2024 $0
Revenue Q2 2026 · Jul 31, 2024 $0